Carmichael Hill & Associates’s Sanofi SNY Stock Holding History

Carmichael Hill & Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-147	Closed	-$7.13K	–	805
2024 Q2	$7.13K	Sell	147 -622	-81%	-$30K	﹤0.01%	603
2024 Q1	$37.4K	Sell	769 -21	-3%	-$1.02K	0.01%	389
2023 Q4	$39.3K	Hold	790	–	–	0.02%	384
2023 Q3	$42.4K	Hold	790	–	–	0.02%	359
2023 Q2	$42.6K	Sell	790 -178	-18%	-$9.58K	0.02%	362
2023 Q1	$52.7K	Hold	968	–	–	0.03%	310
2022 Q4	$46.9K	Hold	968	–	–	0.02%	347
2022 Q3	$37K	Buy	968 +99	+11%	+$4.41K	0.02%	384
2022 Q2	$43K	Hold	869	–	–	0.02%	357
2022 Q1	$45K	Hold	869	–	–	0.02%	384
2021 Q4	$44K	Hold	869	–	–	0.02%	395
2021 Q3	$42K	Hold	869	–	–	0.02%	389
2021 Q2	$46K	Hold	869	–	–	0.02%	370
2021 Q1	$43K	Hold	869	–	–	0.02%	361
2020 Q4	$42K	Sell	869 -50	-5%	-$2.47K	0.02%	345
2020 Q3	$46K	Buy	919 +50	+6%	+$2.57K	0.03%	307
2020 Q2	$44K	Hold	869	–	–	0.03%	291
2020 Q1	$38K	Hold	869	–	–	0.03%	292
2019 Q4	$44K	Buy	+869	New	+$40.7K	0.03%	298

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Carmichael Hill & Associates's SNY Position: Q3 2024 in Review

Carmichael Hill & Associates sold out of Sanofi (SNY) in Q3 2024, closing a stake of 147 shares — an estimated $7.13K sold.

Carmichael Hill & Associates first reported a position in SNY in Q4 2019 and held it in 19 quarters. The position peaked at $52.7K in Q1 2023. 756 funds tracked by Wall St. Rank hold SNY as of Q3 2024.

Carmichael Hill & Associates reported no remaining Sanofi position as of Q3 2024 after selling out during the quarter.
Carmichael Hill & Associates sold 147 Sanofi shares in Q3 2024, an estimated $7.13K.
Carmichael Hill & Associates first reported a position in Sanofi in Q4 2019 and held it in 19 quarters.
Carmichael Hill & Associates's Sanofi position peaked at $52.7K in Q1 2023.
756 funds tracked by Wall St. Rank held Sanofi as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.